Reversine exerts cytotoxic effects through multiple cell death mechanisms in acute lymphoblastic leukemia.

Autor: Carlos JAEG; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, São Paulo, SP, CEP 05508-900, Brazil., Lima K; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, São Paulo, SP, CEP 05508-900, Brazil., Coelho-Silva JL; Department of Medical Images, Hematology and Clinical Oncology, University of São Paulo at Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, SP, Brazil., de Melo Alves-Paiva R; Einstein's Teaching and Research Institute, Albert Einstein Hospital, São Paulo, SP, Brazil., Moreno NC; Department of Microbiology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, SP, Brazil., Vicari HP; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, São Paulo, SP, CEP 05508-900, Brazil., de Souza Santos FP; Einstein's Teaching and Research Institute, Albert Einstein Hospital, São Paulo, SP, Brazil., Hamerschlak N; Einstein's Teaching and Research Institute, Albert Einstein Hospital, São Paulo, SP, Brazil., Costa-Lotufo LV; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, São Paulo, SP, CEP 05508-900, Brazil., Traina F; Department of Medical Images, Hematology and Clinical Oncology, University of São Paulo at Ribeirão Preto Medical School, Ribeirão Preto, São Paulo, SP, Brazil., Machado-Neto JA; Department of Pharmacology, Institute of Biomedical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 1524, São Paulo, SP, CEP 05508-900, Brazil. jamachadoneto@usp.br.

Publikováno v: Cellular oncology (Dordrecht) [Cell Oncol (Dordr)] 2020 Dec; Vol. 43 (6), pp. 1191-1201. Date of Electronic Publication: 2020 Aug 28.

Clinical outcomes in allogeneic haematopoietic stem cell transplantation: A comparison between young and elderly patients. Observational study.

Autor: Chapchap EC; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Kerbauy LN; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Esteves I; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Belucci TR; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Rodrigues M; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Kerbauy FR; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., de Souza Santos FP; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Ribeiro AAF; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil., Hamerschlak N; Dayan-Daycoval Family Hematology and Oncology Center, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.

Publikováno v: European journal of cancer care [Eur J Cancer Care (Engl)] 2019 Sep; Vol. 28 (5), pp. e13122. Date of Electronic Publication: 2019 Jun 30.

A novel mechanism of NPM1 cytoplasmic localization in acute myeloid leukemia: the recurrent gene fusion NPM1-HAUS1.

Autor: Campregher PV; Departments of Hematology and Clinical Pathology, and Research Institute, Hospital Israelita Albert Einstein, Department of Hematology, University of Campinas (Hemocentro - Unicamp), São Paulo, Brazil paulo.campregher@einstein.br., de Oliveira Pereira W; Research Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil., Lisboa B; Research Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil., Puga R; Research Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil., Deolinda ER; Assistant physician and Chief, Hematology Service, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Chief of Cytogenetics Laboratories, Hospital Israelita Albert Einstein, São Paulo, Brazil., Helman R; Department of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil., Marti LC; Research Institute, Hospital Israelita Albert Einstein, São Paulo, Brazil., Guerra JC; Department of Clinical Pathology, Hospital Israelita Albert Einstein, São Paulo, Brazil., Manola KN; Laboratory of Health Physics, Radiobiology & Cytogenetics, National Centre for Scientific Research 'Demokritos', Athens, Greece., Petroni RC; Department of Clinical Pathology, Hospital Israelita Albert Einstein, São Paulo, Brazil., Bezerra AM; Department of Clinical Pathology, Hospital Israelita Albert Einstein, São Paulo, Brazil., Costa FF; Hematology and Hemotherapy Center, School of Medicine, University of Campinas, São Paulo, Brazil., Hamerschlak N; Department of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil., de Souza Santos FP; Department of Hematology, Hospital Israelita Albert Einstein, São Paulo, Brazil.

Publikováno v: Haematologica [Haematologica] 2016 Jul; Vol. 101 (7), pp. e287-90. Date of Electronic Publication: 2016 Apr 01.

Dynamics and management of cytopenias associated with dasatinib therapy in patients with chronic myeloid leukemia in chronic phase after imatinib failure.

Autor: Quintás-Cardama A; Department of Leukemia, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA., De Souza Santos FP, Kantarjian H, O'Brien S, Faderl S, Awais A, Borthakur G, Cortes J

Publikováno v: Cancer [Cancer] 2009 Sep 01; Vol. 115 (17), pp. 3935-43.